Identification

Name

Gonococcal Isolate Surveillance Project

Short name

GISP

Status

Active

Category

System

People
(1) Robert Kirkcaldy, MEDICAL OFFICER, hgl8@cdc.gov
(2) Hillard Weinstock, MEDICAL OFFICER, hsw2@cdc.gov
Organizations
(1) Centers for Disease Control and Prevention (CDC)
Update frequency

Yearly

Created

2012-10-12 21:50:11+00:00

Modified

2016-03-18 21:40:16.832177+00:00

Basic Information

Overview

The Gonococcal Isolate Surveillance Project (GISP) was established in 1986 to monitor trends in antimicrobial susceptibilities of strains of N. gonorrhoeae in the United States, in order to establish a rational basis for the selection of gonococcal therapies. GISP is a collaborative project among selected sexually transmitted diseases (STD) clinics, five regional laboratories, and the Centers for Disease Control and Prevention (CDC).

The GISP monitors trends in antimicrobial susceptibilities of N. gonorrhoeae strains in the United States in order to establish a rational basis for the selection of gonococcal therapies. GISP is a collaborative project among selected sexually transmitted diseases (STD) clinics, five regional laboratories, and the Centers for Disease Control and Prevention (CDC).

Goals
(1) Baseline awareness
Year start

1986

URL http://www.cdc.gov/std/gisp/default.htm
URL (alternate) http://www.cdc.gov/std/gisp/gisp-stats-all-years.htm

Disease and Geography

Locations
(1) Alabama
(2) Arizona
(3) California
(4) Colorado
(5) Florida
(6) Georgia
(7) Hawaii
(8) Illinois
(9) Louisiana
(10) Maryland
(11) Montana
(12) Nevada
(13) New Mexico
(14) New York
(15) North Carolina
(16) Ohio
(17) Oklahoma
(18) Oregon
(19) Pennsylvania
(20) Texas
(21) United States of America
(22) Virginia
(23) Washington
Geography

No

Diseases
(1) Gonorrhea

Datastreams

Data sources
(1) Clinic/Health Care Provider Records
(2) Laboratory Records
(3) Official Reports